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Age-related maculopathy (ARM) remains a poorly understood degeneration. To discover new pathways using contemporary
genomics, proteomics, and immunohistochemistry, validate emerging animal models, and validate new imaging modalities, human
tissues obtained from donor eyes will be essential to ARM research for the foreseeable future. Because fundus appearance is the
clinical diagnostic lingua franca, laboratory investigators adapted these standards to the distinctive appearance of post-mortem tis-
sues in order to identify and stage ARM in donor eyes. Post-mortem tissues oﬀer unique advantages and limitations relative to pre-
mortem tissues for imaging studies. One fellow eye can be used for imaging and the other for correlative laboratory studies, if some
degree of disease stage asymmetry between eyes is acceptable. Histological veriﬁcation is a necessary, albeit challenging, step in val-
idating a grading system.
 2005 Elsevier Ltd. All rights reserved.
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Age-related maculopathy (ARM), the major cause of
vision loss in the elderly, is a poorly understood degen-
eration. Animal models, genetically and surgically in-
duced, abound for choroidal neovascularization, the
principal sight-threatening complication (Ambati,
Ambati, Yoo, Ianchulev, & Adamis, 2003), but models
replicating the early stages of the disease remain an elu-
sive goal, in part because biochemical models of drusen
biogenesis are poorly developed. To discover new bio-
chemical pathways using contemporary genomics, pro-
teomics, and immunohistochemistry, validate emerging
animal models, and validate new imaging modalities,
human tissues obtained from donor eyes will be essential
to ARM research for the foreseeable future. It is instruc-
tive to note the experience of research in other age-related0042-6989/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
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E-mail address: curcio@uab.edu.diseases. Forty years after the characterization of
cholesterol-enriched lesions in coronary artery disease,
20 years after the isolation of tau-protein from Alzhei-
mer brain, and the current widespread availability of
animal models and in vitro systems for both diseases,
high-impact studies using human tissues are still being
published in atherosclerosis and Alzheimer research. Be-
cause imaging plays a key role in identifying and staging
eyes for subsequent analysis, this topic is appropriate for
a neuro-imaging conference. This article will brieﬂy ad-
dress how maculopathy can be visualized in post-mor-
tem eyes and summarize results pertaining to lesion
formation obtained through such studies in my labora-
tory. It is predicated on the concept that even as retinal
imaging approaches previously unimagined levels of
technical reﬁnement, histopathology remains an impor-
tant adjunct approach. Intended for the basic or clinical
investigator with access to human eye tissue, this article
will not comprehensively review ARM histopathology,
nor will it provide detailed clinical information on
selected ARM cases.
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The human macula, deﬁned epidemiologically (Klein
et al., 1991) and anatomically (Polyak, 1941), is 6 mm
in diameter, centered on the fovea, and contained within
the vascular arcades. It subserves the central 21 of visu-
al angle. The retinal layers most directly involved in ear-
ly and late ARM are the retinal pigment epithelium
(RPE), Bruchs membrane (BrM), choriocapillaris
(ChC), and secondarily impacting on the photoreceptors
(Ph). The latter cells, in turn, are segregated within the
image plane of the macula into a small cone-dominated
fovea surrounded by a large rod-dominated parafovea.
BrM, the inner wall of the choroid, a vascular bed with
the bodys highest blood ﬂow, is a 5-layer connective tis-
sue consisting of the basal laminas of the RPE and ChC
on the outside, an elastin layer in the middle, and two
collagenous layers between (Marshall, Hussain, Starita,
Moore, & Patmore, 1998). Early ARM is typiﬁed by the
presence of soft drusen (focal extracellular deposits with
sloping sides) and an abundance of basal deposits. The
latter are diﬀuse lesions located either between the
RPE and its basal lamina (basal laminar deposit, con-
sisting of basement membrane-like material) or, like
drusen, between the RPE basal lamina and the inner
collagenous layer of the BrM (basal linear deposit, con-
sisting of membranous debris). Choroidal neovasculari-
zation in ARM patients consists primarily of in-growth
of ChC vessels into a natural cleavage plane external to
the RPE (Grossniklaus & Green, 2004). Extensive and
sharply deﬁned atrophy of RPE (geographic atrophy)
can occur as an end-stage of a non-exudative degenera-
tion or concomitantly with neovascularization.1 PubMed; June 23, 2005; age-related macular degeneration histo-
pathology; abstract in English; human or non-human primate.3. Clinical grading systems
To achieve twin goals of objectivity and reproducibil-
ity for ARM diagnosis and staging, clinical researchers
now rely on standard fundus photographs rather than
clinical examination. Features common to clinical
ARM grading systems were derived from those devel-
oped for diabetic retinopathy (DRSRG, 1981; ETDRS,
1991). These include the use of standard lighting condi-
tions that emphasize drusen or subtle alterations in RPE
pigmentation, a fovea-centered grid which deﬁnes stan-
dard subﬁelds for assignment of lesion location, stan-
dard circles (based on choroidal vessel diameter) which
can be used to measure diameter and area, and on-going
reliability assessment by cross-checking individual grad-
ers and by periodic re-grading of a standard test photo-
graph set. Although reliable, these grading systems still
await histological validation, a challenging goal, because
few ARM eyes come to histopathology. To date only
two studies have illustrated micrographs of lesions
previously graded using accepted clinical standards(Curcio, Medeiros, & Millican, 1998; Sarks, Arnold,
Killingsworth, & Sarks, 1999).
Population-based epidemiologic studies e.g., (Klein,
Klein, & Linton, 1992; Mitchell, Smith, Attebo, &
Wang, 1995; Vingerling et al., 1995) rely on the Wiscon-
sin ARM Grading System or the related International
System, which deﬁnes an early and late stage. Clinical
studies and clinical trials following the lead of the
N.E.I.-funded Age-related Eye Disease Study (AREDS)
(2001) will increasingly utilize the AREDS grading sys-
tem. This formulation resembles the WARMGS in le-
sion deﬁnition, but diﬀers from the WARMGS in that
four stages of maculopathy are assigned rather than
two. A progression between the ﬁrst three stages are im-
plied but not proven by this scheme.4. Previous literature on ARM clinicopathologic
correlation
A literature search1 reveals roughly 130 studies since
1974 (half of which appeared since 1998) that directly
examined eyes from known ARM patients with light
or electron microscopic tissue methods. These investiga-
tions can be divided into several main genres, as illus-
trated by the following: (1) extensive series of eyes
from a single hospital population, supplemented by clin-
ical information with pre-mortem imaging (Sarks, 1976;
Sarks et al., 1999), and derivative small sub-series (Pen-
fold, Killingsworth, & Sarks, 1984); (2) extensive series
of eyes with clinical information including pre-mortem
imaging from eye pathology laboratories working close-
ly with local eye banks (Bressler, Silva, Bressler, Fine, &
Green, 1994; Green & Enger, 1993; Green & Key, 1977);
(3) extensive series of clinically undocumented eyes from
eye pathology laboratories working closely with local
eye banks (Biswas & Raman, 2002; Kliﬀen, Mooy, Luid-
er, Huijmans, & Kerkvliet, 1996; Loeﬄer & Lee, 1986;
Spraul & Grossniklaus, 1997; van der Schaft et al.,
1992); (4) extensive series of eyes from eye pathology
laboratories working with autopsy services (Gartner &
Henkind, 1981; Hoshino, Mizuno, & Ichikawa, 1984);
(5) extensive series harvested from local eye banks for
research purposes, with varying degrees of clinical doc-
umentation (Chong et al., 2005; Curcio, Presley, Milli-
can, & Medeiros, 2005; Olsen & Feng, 2004); (5) series
of varying sizes gleaned from an eye bank network coor-
dinated through a non-proﬁt organization, foundation,
or individual laboratory (Bhutto et al., 2004; Hahn, Mi-
lam, & Dunaief, 2003; Kamei & Hollyﬁeld, 1999; Mar-
morstein et al., 2002). To date there has been little
move towards standardizing ARM histopathologic
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standardizing fundus appearance criteria (Bird et al.,
2004). Other sources of ARM-relevant tissues consist
of aged non-human primates (Chang et al., 1998; Hope
et al., 1992; Johnson et al., 2005; Umeda et al., 2005)
whose drusenoid-like lesions may well resemble human
drusen at the molecular level, and surgically excised
sub-macular neovascular membranes (Ambati et al.,
2003; Grossniklaus & Green, 2004), which since 1994
provided a gold standard for rapid availability and con-
sistency of tissues for immunohistochemistry and recent-
ly, cell culture (Schlunck, Martin, Agostini, Camatta, &
Hansen, 2002).5. Diﬀerences between pre- and post-mortem fundus
imaging
Because fundus appearance is the diagnostic lingua
franca in the clinic, laboratory investigators developed
methods to identify and stage ARM in donor eyes in
post-mortem fundus. Another impetus for this eﬀort
is the fact that eye bank eyes have limited ophthalmic
histories available at the time of accession, because
such records are not required by regulatory agencies,
at least in the US. Therefore, it is desirable to stage
eyes strictly on the basis of features visible within the
eye itself. To achieve the same goals of objectivity
and reproducibility that motivated clinical researchers
to rely on standard fundus photographs rather than
clinical examination, it is possible to rely on standard
photographs of the post-mortem fundus over gross
examination.
Retinal edema and/or detachment can appreciably re-
duce the visibility of posterior pigmented tissues. Obser-
vations in fresh eyes indicate that these changes occur
post-mortem and do not worsen markedly with ﬁxation.
In addition, choroidal vessels empty after death, making
it diﬃcult to assess minor pigmentary variations in the
plane of the RPE against the undulating background
of pale vessels and dark interstitial tissue. Therefore,
applying methods for grading clinical fundus photo-
graphs directly to preserved donor eyes is unwarranted,
given the distinctly diﬀerent detail visible in pre- and
post-mortem fundus. The challenge, then, is to adapt
clinical schemes to the constraints of post-mortem
material.
Nevertheless, post-mortem tissues oﬀer advantages
relative to pre-mortem imaging as a research resource,
as follows: (1) the anterior segment and vitreous can be
removed to optimize the view of retina and choroid; (2)
globes can be illuminated directly, tangentially, and
trans-sclerally to maximize contrast of drusen and/or
pigmentary changes; (3) the retina can be removed
revealing underlying chorioretinal pathology in greater
detail; (4) stereoscopic viewing and imaging can revealanteriorly elevated structures; (5) accurate internal
magniﬁcation standards can be used. Through a fellow
eye design, one eye can be designated for ARM grad-
ing and the other for correlative studies, although not
without some compromise in diagnostic precision.
Much ARM pathology is bilaterally symmetrical in
type if not degree of severity (drusen, RPE hyperpig-
mentation) (Wang, Mitchell, Smith, & Cumming,
1998), and 36% of early ARM, 26% of late ARM
would be missed if only one eye is graded (Klein
et al., 2003).
The challenges of post-mortem tissues are: (1) post-
mortem edema of the inner retina can opacify the tissue
and obscure parafoveal pathology; (2) sub-retinal ﬂuid
occurs frequently, especially in the peripapillary area
and occasionally in conjunction with pre-retinal ﬂuid,
and cannot be used as a marker for exudative ARM;
(3) intra-retinal hemorrhage occurs frequently; (4) drain-
ing of blood from choroidal vessels leaves an undulating
dark and light background which obscures visualization
of overlying drusen; (4) the retina must be left in situ to
localize macular landmarks but should be removed for
best viewing of underlying RPE/choroid; (5) individual
diﬀerences in pigmentation density and hue are com-
pounded by individual diﬀerences in post-mortem
change.6. MGS and ALARMGS: Methods for post-mortem
fundus imaging
Two recent systems seek to document ARM mor-
phology in permanent photographic records paralleling
clinical examination: (1) Alabama Age-related Macu-
lopathy Grading System (ALARMGS) (Curcio et al.,
1998), based on WARMGS, using 35 mm color ﬁlm
and stereoscopic imaging for preserved eyes destined
for histopathology; (2) Minnesota Grading System
(MGS), (Olsen & Feng, 2004), based on AREDS, using
digital color images, single and stereo, for fresh eyes des-
tined for genomics/proteomics. These approaches are
compared in Table 1.
The MGS and ALARMGS have in common the use
of diﬀerent illumination techniques—direct (epi-illumi-
nation), tangential, and indirect (trans-scleral). Tangen-
tial illumination, aﬀorded by angling a gooseneck
ﬁber-optic element (MGS) or using the oblique illumina-
tion from a dark-ﬁeld microscopy base (ALARMGS)
highlights focal and diﬀuse changes in the RPE, similar
to the eﬀect of sunlight shining across a mountain range.
Speciﬁc macular features are best illustrated with a
combination of illumination techniques. Drusen,
pigment change, and unevenness of elevation are more
visible with direct, trans-scleral, and tangential lighting,
respectively. Distinctive druse types (calciﬁed, basal
laminar) are visible.
Table 1
Methods for imaging maculopathy in post-mortem retina
ALARMGS MGS
ARM knowledge base Histopathologically deﬁned cases Clinical observation
Purpose of staging Histopathological analysis Genomics/proteomics
Tissue Horizontal strip with fovea, optic nerve head,
nasal &temporal periphery
Whole globe, anterior segment removed by
circumferential incision at pars plana
Preservation status Mixed aldehyde ﬁxation Fresh
Images obtained Retina on, stereo Retina on and retina oﬀ, mono or stereo
Stereo microscope Nikon SMZ-U, side-port extension Nikon SMZ 1500
Lighting equipment (epi-,
light source; trans-, light source)
Fixed location ﬁber optic ring; halogen; dark-ﬁeld
base; halogen
Gooseneck ﬁber optic, halogen; ﬂat plate diﬀuse
illumination
Illumination modes Direct ± oblique trans-scleral Direct ± tangential ± oblique trans-scleral
Camera Nikon UFXII Sony DXC-S500
Media EPJ320T 35 mm ﬁlm Digital camera
Magniﬁcation standard External; photograph of ruler Internal; 1 mm ruby sphere placed on optic nerve head
Image viewing Light box, ﬂuorescent, color temperature 5000 Computer monitor, green ﬁlter, 10%, digitally applied
EDTRS/WARMGS grid On acetate; centered and taped to 35 mm slide Digital; centered using ‘‘retina on’’ image;
proportional triangle and choroidal landmarks
indicate sub-foveal RPE on ‘‘retina oﬀ’’ image
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ALARMGS employs a horizontal belt containing the
macula stabilized in a polystyrene cup and submerged in
buﬀer to eliminate specular reﬂections oﬀ the tissue sur-
face. Complete removal of macular vitreous was essential
for reducing adhesion of dirt and bubbles. In contrast, the
MGS employs whole globes with anterior segment re-
moved. TheMGS andALARMGS also diﬀer in themeth-
od used to center and calibrate a grading grid. The
ALARMGSuses aWARMGSgrid, its diameter calibrat-
ed to match 6 mm on the retina as captured 35 mm ﬁlm at
standard magniﬁcations and printed on a plastic overlay.
The overlay is physically aﬃxed to a 35 mm slide. In con-
trast, the MGS employs a digital proportional triangle
that denotes within digital images the fovea and two
prominent choroidal landmarks before and after removal
of the neurosensory retina. Then, a grid overlay is adjust-
ed for an internal magniﬁcation standard on each image
(a 1000-lm diameter ruby sphere placed on the optic
nerve head). By matching the inner circle to the ruby
sphere, all other circles are proportionally modiﬁed (via
Adobe Illustrator software).7. Clinicopathologic correlation using ALARMGS images
Selected images from human eyes accessioned over
10 years are shown in Fig. 1 (gross photographs; see
Supplementary Figure for stereo pair versions) and
Fig. 2 (histopathology), with the intent of illustrating
microscopic correlates of fundus features. Original
publications contain more detail and/or additional
illustrations (Curcio & Millican, 1999; Curcio et al.,
2005; Curcio, Presley, Millican, et al., 2005; Malek,
Li, Guidry, Medeiros, & Curcio, 2003; Curcio et al.,
1998).In normal aged maculas (Fig. 1A), the front stereo
plane shows intrinsic vessels of the neurosensory retina,
deeply pigmented foveal retina, translucent parafoveal
retina, and the back stereo plane shows undulating
dark and light stripes in underlying empty choroidal
vessels. In 1 lm-thick sections (Fig. 2A), rod and cone
nuclei appear in diﬀerent sublayers (cones, outer; rods,
inner) of ONL, they diﬀer in the relative ratio of
euchromatin to heterochromatin (high for cones, low
for rods), and the distinctly delicate outer segments
are bent.
In an eye with clinically ‘‘mild’’ ARM and 20/30
acuity, small dome-shaped drusen, visible through
depth of small fold created by post-enucleation edema
(Fig. 1B), has ultrastructurally identiﬁed membranous
contents that are continuous with a layer of basal lin-
ear deposit (Fig. 2B). In an eye with clinically de-
scribed ‘‘dry ARM and pigment changes’’ and 20/40
acuity, large pale drusen, associated with hyperpig-
mented RPE, are visible at fovea and less so through
edematous parafovea (Fig. 1C). The largest foveal
druse is encased by basal laminar deposit, contains
membranous debris, and lakes of neutral lipid
(Fig. 2C). In a clinically undocumented eye exhibiting
a large foveal druse (Fig. 1D), ﬁlipin histochemistry
reveals esteriﬁed cholesterol in lakes within the druse
and BrM (Fig. 2D) and unesteriﬁed cholesterol in a
diﬀuse pattern within the druse, BrM, and all chorio-
retinal cellular membranes. To our knowledge, this
druse is the ﬁrst that is both funduscopically visible
and chemically characterized. In a clinically undocu-
mented eye with geographic atrophy of RPE, inactive
ﬁbrotic choroidal neovascularization, and intra-retinal
pigment migration (Fig. 1E), an unusually thick and
pale basal laminar deposit overlies a prominent basal
linear deposit comprised of neutral lipid pools
Fig. 1. Post-mortem fundus in aged and ARM eyes. Fovea is at the center of all panels. Bars, 1 mm: (A) right eye shows a normal macula with deeply
pigmented foveal retina, translucent parafoveal retina with retinal vessels (arrows), and undulating dark and light stripes in underlying choroid
(arrowheads) (87-year-old man). (B) Right eye shows small drusen (arrow) visible through depth of small fold created by post-enucleation edema
(arrowheads) (60-year-old man). (C) Right eye shows large drusen (arrow) with hyperpigmented RPE, visible at fovea and less so through edematous
parafovea (74-year-old man). (D) Left eye shows prominent druse in foveal center of eye with little post-mortem change (85-year-old man). (E) Right
eye shows geographic atrophy of RPE (arrowheads), scar (s) denoting inactive ﬁbrotic choroidal neovascularization temporal to the fovea, and intra-
retinal pigment migration (arrow). Asterisk, optic nerve head. (87-year-old man). (F) Right eye shows anteriorly migrated pigment clumps (arrows)
superior-nasal to the fovea (90-year-old-woman). (G) Right eye shows large calciﬁed drusen (Dr) overlying a triangular area of hypopigmentation
(arrows) bordered by hyperpigmentation (83-year-old woman).
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riorly migrated pigment clumps and RPE hypopig-
mentation nasal to the fovea (Fig. 1F), the most
prominent pigmentary change is hyperpigmented/hy-
pertrophic balloon-like RPE cells sloughed from their
monolayer overlying basal laminar deposit into the
subretinal space (Fig. 2F).
In an eye from a donor with 20/60 acuity and cumu-
lous-like calciﬁed drusen, a triangular area of hypopig-
mentation bounded by hyperpigmentation (Fig. 1G)delimits a serous RPE detachment with pigmented cells
(presumed RPE) on BrM (Fig. 2G).8. Conclusions and directions
In conclusion, ARM morphology is visible in the
post-mortem fundus, enabling the large scale harvest-
ing of ARM eyes from the donor population. Clinical
and epidemiologic grading systems are adaptable to the
Fig. 2. Histopathology of aged and ARM eyes. 1 lm-thick, toluidine-O-blue stained sections (A,B,C,E,F,G); adjacent cryosections stained with
ﬁlipin (D). Bars, 20 lm unless noted. (A) Parafoveal area of normal macula has mixed rods (r) and cones (c), thin Bruchs membrane (bracketing
arrowheads), and choriocapillaris (ChC). HFL, Henle ﬁber layer; ONL, outer nuclear layer; IS, inner segments; OS, outer segments; RPE, retinal
pigment epithelium. (87-year-old man). (B) Druse with membranous contents is continuous with a layer of basal linear deposit (bracketing
arrowheads). (60-year-old man). (C) Large druse (Dr), encased by basal laminar deposit (asterisk), contains membranous debris and lakes of neutral
lipid (L) (74-year-old man). (D) Esteriﬁed cholesterol, in lakes (top panel), and unesteriﬁed cholesterol (bottom panel) in the same solitary druse (Dr).
Bar, 50 lm (85-year-old man). (E) A thick, pale basal laminar deposit (asterisk) overlies prominent basal linear deposit (arrow) comprised of neutral
lipid pools, post-ﬁxed by osmium paraphenylenediamine—tannic acid method (inset, arrow; bar, 0.5 lm) (87-year-old man). (F) Lower magniﬁcation
view of fovea with thick basal laminar deposits and RPE cells (arrow) sloughed into the subretinal space. Bar, 100 lm (90-year-old-woman). (G) A
serous (s) detachment of the RPE is ﬂanked by hyperpigmented RPE (h), pigment granules in migration (white arrow), and photoreceptors (p)
lacking outer segments. Presumed RPE cells line Bruchs membrane (black arrow) (83-year-old woman).
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chemical/histopathologic analysis, fundus visualization,
systemic tests, can further focus the power of these cor-
relations, especially given the potential for retrospective
screening of archived material, is underscored by recent
work linking polymorphisms in complement factor H
and ARM (Edwards et al., 2005; Hageman et al.,
2005; Haines et al., 2005; Klein et al., 2005). Of thefuture challenges, perhaps the most signiﬁcant is the
continued validation of grading systems via histopa-
thology, in part because of the long time-scale over
which usable specimens with bona ﬁde ARM are ob-
tained from systematic harvesting of donor eyes. Cho-
lesterol localization in lesions should stimulate interest
in imaging modalities that provide distinctive signa-
tures for the lipid-rich plaque core in atherosclerotic
3502 C.A. Curcio / Vision Research 45 (2005) 3496–3503arterial intima (Kramer, 2002; Regar, Schaar, Mont,
Virmani, & Serruys, 2003; Schoenhagen & Nissen,
2003). These include, but are not restricted to, intravas-
cular ultrasound, optical coherence tomography, and
magnetic resonance imaging. Many of these modalities
are already commonly used by ophthalmologists or
other physicians regularly assessing ophthalmologists
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